Connor O’Leary

595 total citations
29 papers, 387 citations indexed

About

Connor O’Leary is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Connor O’Leary has authored 29 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Connor O’Leary's work include Cancer Genomics and Diagnostics (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Connor O’Leary is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Connor O’Leary collaborates with scholars based in Australia, Ireland and United States. Connor O’Leary's co-authors include Kenneth J. O’Byrne, Derek J. Richard, Rahul Ladwa, Arutha Kulasinghe, Nick Pavlakis, Joshua T. Burgess, Vladimir Andelkovic, Fred R. Hirsch, Majid Ebrahimi Warkiani and Caicun Zhou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Analytical Chemistry.

In The Last Decade

Connor O’Leary

26 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Connor O’Leary Australia 10 178 155 147 106 39 29 387
Silvia Bolzonello Italy 6 235 1.3× 137 0.9× 138 0.9× 110 1.0× 50 1.3× 13 435
Zhong-Hua Wang China 6 179 1.0× 116 0.7× 164 1.1× 170 1.6× 37 0.9× 8 413
Jun Koshio Japan 6 247 1.4× 125 0.8× 167 1.1× 87 0.8× 27 0.7× 11 464
Xi-Chun Hu China 9 112 0.6× 71 0.5× 112 0.8× 117 1.1× 55 1.4× 12 318
Pasqualina Giordano Italy 14 270 1.5× 162 1.0× 162 1.1× 50 0.5× 35 0.9× 31 505
Bavanthi Balakrishnar Australia 10 195 1.1× 186 1.2× 160 1.1× 114 1.1× 9 0.2× 25 469
Hisayuki Kobayashi Japan 14 301 1.7× 168 1.1× 106 0.7× 81 0.8× 17 0.4× 20 484
Hirokuni Ikeda Japan 10 205 1.2× 125 0.8× 195 1.3× 109 1.0× 62 1.6× 44 472
Enrique Sanz‐García Spain 6 234 1.3× 123 0.8× 130 0.9× 161 1.5× 125 3.2× 18 401
Depei Huang China 10 340 1.9× 197 1.3× 90 0.6× 81 0.8× 37 0.9× 24 482

Countries citing papers authored by Connor O’Leary

Since Specialization
Citations

This map shows the geographic impact of Connor O’Leary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Connor O’Leary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Connor O’Leary more than expected).

Fields of papers citing papers by Connor O’Leary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Connor O’Leary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Connor O’Leary. The network helps show where Connor O’Leary may publish in the future.

Co-authorship network of co-authors of Connor O’Leary

This figure shows the co-authorship network connecting the top 25 collaborators of Connor O’Leary. A scholar is included among the top collaborators of Connor O’Leary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Connor O’Leary. Connor O’Leary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Ming, et al.. (2023). Targeted Therapies for Kirsten Rat Sarcoma (KRAS) G12C Mutant Metastatic Non-Small-Cell Lung Cancers. Cancers. 15(23). 5582–5582. 2 indexed citations
2.
Ahmed, Mostak, Alain Wuethrich, Paul N. Mainwaring, et al.. (2023). Liquid Biopsy Snapshots of Key Phosphoproteomic Pathways in Lung Cancer Patients for Diagnosis and Therapy Monitoring. Analytical Chemistry. 95(22). 8522–8532. 5 indexed citations
3.
Kapeleris, Joanna, Juliana Müller Bark, Darryl Irwin, et al.. (2022). Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer. Heliyon. 8(7). e09971–e09971. 15 indexed citations
4.
Dave, Keyur A., Christopher J. Molloy, Neha S. Gandhi, et al.. (2021). Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer. Frontiers in Oncology. 11. 615967–615967. 6 indexed citations
5.
Fernández, Alejandra, Connor O’Leary, Kenneth J. O’Byrne, et al.. (2021). Epigenetic Mechanisms in DNA Double Strand Break Repair: A Clinical Review. Frontiers in Molecular Biosciences. 8. 685440–685440. 33 indexed citations
6.
Kulasinghe, Arutha, Connor O’Leary, James Monkman, et al.. (2021). The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC). Lung Cancer. 160. 73–77. 7 indexed citations
7.
Kapeleris, Joanna, Arutha Kulasinghe, Majid Ebrahimi Warkiani, et al.. (2020). Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer. Translational Lung Cancer Research. 9(5). 1795–1809. 32 indexed citations
8.
Burgess, Joshua T., Maddison Rose, Didier Boucher, et al.. (2020). The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer. Frontiers in Oncology. 10. 41 indexed citations
9.
Monkman, James, Touraj Taheri, Majid Ebrahimi Warkiani, et al.. (2020). High-Plex and High-Throughput Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC). Cancers. 12(12). 3551–3551. 33 indexed citations
10.
O’Leary, Connor, et al.. (2020). Challenges associated with systemic therapy for older patients with inoperable non-small cell lung cancer. Expert Opinion on Pharmacotherapy. 21(17). 2185–2194. 2 indexed citations
11.
O’Byrne, Kenneth J., Joanna Kapeleris, Arutha Kulasinghe, et al.. (2020). Culture of circulating tumour cells derived from non-small cell lung cancer.. Journal of Clinical Oncology. 38(15_suppl). e21692–e21692.
12.
O’Leary, Connor, et al.. (2020). Unilateral autoimmune inner ear disease in a patient with lung cancer treated with nivolumab. Oxford Medical Case Reports. 2020(9). omaa077–omaa077. 8 indexed citations
13.
O’Leary, Connor, Ming Tang, Arutha Kulasinghe, et al.. (2020). Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC). Pharmaceuticals. 13(10). 273–273. 53 indexed citations
14.
O’Leary, Connor, Vladimir Andelkovic, Rahul Ladwa, et al.. (2019). Targeting BRAF mutations in non-small cell lung cancer. Translational Lung Cancer Research. 8(6). 1119–1124. 73 indexed citations
15.
O’Leary, Connor, et al.. (2019). Professional burnout, work patterns and career satisfaction in medical oncologists in Ireland. Irish Journal of Medical Science (1971 -). 189(2). 711–718. 7 indexed citations
16.
O’Leary, Connor, et al.. (2018). Epidermal growth factor receptor mutated oligometastatic adeno-squamous lung cancer transformation to small cell lung cancer. Oxford Medical Case Reports. 2018(10). omy078–omy078. 2 indexed citations
17.
O’Leary, Connor, Haley Ellis, & Michaela J. Higgins. (2016). Extended adjuvant endocrine therapy in hormone-receptor-positive early breast cancer. Current Opinion in Oncology. 28(6). 455–460. 7 indexed citations
18.
O’Leary, Connor, et al.. (2016). Toxicities in immunotherapy: Can they predict response?. Journal of Clinical Oncology. 34(15_suppl). e14534–e14534. 8 indexed citations
19.
O’Leary, Connor, et al.. (2016). Scrotal Involvement with Testicular Nonseminomatous Germ Cell Tumour. Case Reports in Oncological Medicine. 2016. 1–3. 1 indexed citations
20.
O’Leary, Connor, Jane McCarthy, Misty D. Humphries, Fergus Shanahan, & Eamonn M.M. Quigley. (2003). The prophylactic use of a proton pump inhibitor before food and alcohol. Alimentary Pharmacology & Therapeutics. 17(5). 683–686. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Bolzonello Breakdown of academic impact, for papers by Zhong-Hua Wang Breakdown of academic impact, for papers by Jun Koshio Breakdown of academic impact, for papers by Xi-Chun Hu Breakdown of academic impact, for papers by Pasqualina Giordano Breakdown of academic impact, for papers by Bavanthi Balakrishnar Breakdown of academic impact, for papers by Hisayuki Kobayashi Breakdown of academic impact, for papers by Hirokuni Ikeda Breakdown of academic impact, for papers by Enrique Sanz‐García Breakdown of academic impact, for papers by Depei Huang
Rankless by CCL
2026